Skip to content

Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use

Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use and Evaluation of the Effectiveness Through the Self Awareness of the Research, of Clinical Evaluations and Instrumental Measurements

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02695706
Enrollment
35
Registered
2016-03-01
Start date
2016-04-30
Completion date
2016-07-31
Last updated
2016-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Diabetes, Skin acceptability, Clinical Research

Brief summary

The measured product in this research is a product for topical use, Laboratoires Mercurochrome Reparador e Protetor. The expected benefit to the use of the product is the improvement in skin hydration as measured by self perception of participant research and clinical evaluation and improvement in local microcirculation, assessed by instrumental measurements in feet of the study participants.

Detailed description

The objectives of this study is to verify the skin acceptability through the non-occurrence of adverse events and cutaneous sensations of discomfort, evaluate the moisturizing efficacy of the product through self perception of research participants and dermatological clinical evaluation to assess the improvement in local microcirculation by performing of instrumental measurements in the feet of diabetic participants, product Laboratoires Mercurochrome Repairer and Protector referred by LM FARMA INDUSTRIAL LTDA. For this research, will be recruited up to 35 research participants who meet the inclusion / exclusion described in items 9.4 and 9.5 of the research protocol, to achieve a number of completion of 30 participants. Be recruited participants from both sexes, aged 18 and 65, which have dry skin on the feet and they are people with diabetes whose condition is stabilized.

Interventions

DEVICELaboratoires Mercurochrome Reparador

Developed for the treatment of damaged or fragile skin.

Sponsors

LM Farma Indústria e Comércio Ltda.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants healthy research; * Intact skin on feet - grade 0 in the Wagner scale; * Agreement to adhere to the procedures and requirements of the study and attend to the Office (s) day (s) and time (s) set (s) for evaluations; * Ability to consent to participate in writing; * Age 18 to 65 years; * Research Participants of both sexes - including at least three men; * Introducing dry skin on feet - dermatological proof. * Participants with diabetes whose condition is stabilized

Exclusion criteria

* Pregnancy and lactation; skin pathology in the product application area; * immune impairment; * Current use of these medications for topical or systemic use: corticoid, immunosuppressants, antihistamines, anticoagulants or birth; * Skin diseases: psoriasis, vitiligo, atopic dermatitis; * History of reaction to the category of the product tested; * Other diseases or medications that may interfere directly in the study or to endanger the health of the research participant.

Design outcomes

Primary

MeasureTime frameDescription
Skin acceptability through the self perception of patients.2 monthsMeasure the skin acceptability through the self perception of patients with the daily use of the product adding in a questionnaire the product effectiveness.

Secondary

MeasureTime frameDescription
Instrumental Performance Measures2 monthsInstrumental measurements will be carried out through the Skin-Thermometer ST equipment 500 - Courage + Khazaka in the feet of participants with the aid of a dermatologist.

Contacts

Primary ContactNesser C Oliveira, Graduated
n.oliveira@br.urgo.com551230021316
Backup ContactSheila M Vieira, Graduated
s.vieira@br.urgo.com551232021316

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026